412 related articles for article (PubMed ID: 16970872)
21. Psychopharmacology of obsessive-compulsive disorder in Tourette syndrome.
King RA; Riddle MA; Goodman WK
Adv Neurol; 1992; 58():283-91. PubMed ID: 1414634
[No Abstract] [Full Text] [Related]
22. A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder.
McDougle CJ; Epperson CN; Pelton GH; Wasylink S; Price LH
Arch Gen Psychiatry; 2000 Aug; 57(8):794-801. PubMed ID: 10920469
[TBL] [Abstract][Full Text] [Related]
23. Obsessive compulsive disorder treatment in patients with Down syndrome: a case series.
Sutor B; Hansen MR; Black JL
Downs Syndr Res Pract; 2006 Jul; 10(1):1-3. PubMed ID: 16869367
[TBL] [Abstract][Full Text] [Related]
24. The efficacy of fluvoxamine in obsessive-compulsive disorder: effects of comorbid chronic tic disorder.
McDougle CJ; Goodman WK; Leckman JF; Barr LC; Heninger GR; Price LH
J Clin Psychopharmacol; 1993 Oct; 13(5):354-8. PubMed ID: 8227493
[TBL] [Abstract][Full Text] [Related]
25. Pharmacotherapy for tics in adult patients with Tourette syndrome and other tic disorders.
Badenoch J; Cavanna AE
Neurol Sci; 2020 Jul; 41(7):1923-1926. PubMed ID: 32170503
[TBL] [Abstract][Full Text] [Related]
26. [Effectiveness and tolerability of addition of risperidone in obsessive-compulsive disorder with poor response to serotonin reuptake inhibitors].
Arias Horcajadas F; Soto JA; García-Cantalapiedra MJ; Rodríguez Calvin JL; Morales J; Salgado M
Actas Esp Psiquiatr; 2006; 34(3):147-52. PubMed ID: 16736387
[TBL] [Abstract][Full Text] [Related]
27. Pharmacotherapy for obsessive compulsive disorder in clinical practice - Data of 842 inpatients from the International AMSP Project between 1994 and 2012.
Poppe C; Müller ST; Greil W; Walder A; Grohmann R; Stübner S
J Affect Disord; 2016 Aug; 200():89-96. PubMed ID: 27130958
[TBL] [Abstract][Full Text] [Related]
28. Olanzapine addition in obsessive-compulsive disorder refractory to selective serotonin reuptake inhibitors: an open-label case series.
Weiss EL; Potenza MN; McDougle CJ; Epperson CN
J Clin Psychiatry; 1999 Aug; 60(8):524-7. PubMed ID: 10485634
[TBL] [Abstract][Full Text] [Related]
29. Sertraline in children and adolescents with obsessive-compulsive disorder: a multicenter randomized controlled trial.
March JS; Biederman J; Wolkow R; Safferman A; Mardekian J; Cook EH; Cutler NR; Dominguez R; Ferguson J; Muller B; Riesenberg R; Rosenthal M; Sallee FR; Wagner KD; Steiner H
JAMA; 1998 Nov; 280(20):1752-6. PubMed ID: 9842950
[TBL] [Abstract][Full Text] [Related]
30. Tics and fits. The current status of Gilles de la Tourette syndrome and its relationship with epilepsy.
Rickards H
Seizure; 1995 Dec; 4(4):259-66. PubMed ID: 8719917
[TBL] [Abstract][Full Text] [Related]
31. The use of antipsychotics in obsessive compulsive disorder.
Conti D; Girone N; Boscacci M; Casati L; Cassina N; Cerolini L; Giacovelli L; Viganò C; Conde MM; Cremaschi L; Dell'Osso BM
Hum Psychopharmacol; 2024 May; 39(3):e2893. PubMed ID: 38340275
[TBL] [Abstract][Full Text] [Related]
32. [Treatment of obsessive-compulsive disorder in an adult].
Kähkönen S; Holmberg N
Duodecim; 2010; 126(11):1310-6. PubMed ID: 20681354
[TBL] [Abstract][Full Text] [Related]
33. Antipsychotic augmentation of selective serotonin reuptake inhibitors in resistant tic-related obsessive-compulsive disorder in children and adolescents: a naturalistic comparative study.
Masi G; Pfanner C; Brovedani P
J Psychiatr Res; 2013 Aug; 47(8):1007-12. PubMed ID: 23664673
[TBL] [Abstract][Full Text] [Related]
34. Antipsychotic Augmentation of Serotonin Reuptake Inhibitors in Treatment-Resistant Obsessive-Compulsive Disorder: An Update Meta-Analysis of Double-Blind, Randomized, Placebo-Controlled Trials.
Dold M; Aigner M; Lanzenberger R; Kasper S
Int J Neuropsychopharmacol; 2015 May; 18(9):. PubMed ID: 25939614
[TBL] [Abstract][Full Text] [Related]
35. [Evidence-based pharmacotherapy and other somatic treatment approaches for obsessive-compulsive disorder: state of the art].
Kordon A; Zurowski B; Wahl K; Hohagen F
Nervenarzt; 2011 Mar; 82(3):319-20, 322-4. PubMed ID: 21340636
[TBL] [Abstract][Full Text] [Related]
36. The presence of comorbidity in Tourette syndrome increases the need for pharmacological treatment.
Debes NM; Hjalgrim H; Skov L
J Child Neurol; 2009 Dec; 24(12):1504-12. PubMed ID: 19494355
[TBL] [Abstract][Full Text] [Related]
37. Neurobiology of obsessive compulsive disorder.
Wright M; Hewlett WA
Compr Ther; 1994; 20(2):95-100. PubMed ID: 7911407
[No Abstract] [Full Text] [Related]
38. Psychopharmacological Treatment of Obsessive-Compulsive Disorder (OCD).
Del Casale A; Sorice S; Padovano A; Simmaco M; Ferracuti S; Lamis DA; Rapinesi C; Sani G; Girardi P; Kotzalidis GD; Pompili M
Curr Neuropharmacol; 2019; 17(8):710-736. PubMed ID: 30101713
[TBL] [Abstract][Full Text] [Related]
39. A randomized, controlled trial of cognitive-behavioral therapy for augmenting pharmacotherapy in obsessive-compulsive disorder.
Simpson HB; Foa EB; Liebowitz MR; Ledley DR; Huppert JD; Cahill S; Vermes D; Schmidt AB; Hembree E; Franklin M; Campeas R; Hahn CG; Petkova E
Am J Psychiatry; 2008 May; 165(5):621-30. PubMed ID: 18316422
[TBL] [Abstract][Full Text] [Related]
40. Obsessive compulsive disorder: diagnosis and management.
Fenske JN; Schwenk TL
Am Fam Physician; 2009 Aug; 80(3):239-45. PubMed ID: 19621834
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
